Developing and Testing the Opioid Rapid Response System

开发和测试阿片类药物快速反应系统

• 批准号: 10304577
• 负责人: Michael Hecht
• 金额: $ 5.2万
• 依托单位: REAL PREVENTION, LLC
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-30 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10304577
• 关键词: 911 call; Adoption; Communities; County; Event; Fire - disasters; Geography; Goals; Health; Heart Arrest; Innovation Corps; Interview; Life; Link; Methods; Naloxone; Narcan; Opioid; Overdose; Persons; Phase; Pilot Projects; Police; Procedures; Process; Protocols documentation; Reporting; Research; Sales; Savings; Services; Standardization; System; Testing; Training; commercialization; cost; density; design; effective intervention; evidence base; implementation science; meetings; opioid epidemic; opioid mortality; opioid overdose; prevent; recruit; response; usability

The goal of this project is to prevent deaths from opioid overdoses through developing and commercializing the Opioid Rapid Response System (ORRS). This system is designed to reduce the cost of the opioid epidemic by developing standardized and effective procedures for recruiting and training citizen responders to use the PulsePoint app to administer life-saving naloxone/Narcan. This i-Corps supplement will assess the commercialization potential for ORRS and develop a plan for dissemination.

该项目的目标是通过开发和使用阿片类药物， 阿片类药物快速反应系统（ORRS）该系统旨在降低成本 通过制定标准化和有效的招募和培训程序， 公民响应者使用PulsePoint应用程序来管理拯救生命的纳洛酮/纳洛酮。这个i-Corps 补充报告将评估ORRS的商业化潜力，并制定传播计划。

项目成果

Development of opioid rapid response system: Protocol for a randomized controlled trial.

• DOI: 10.1016/j.cct.2022.106727
• 发表时间: 2022-04
• 期刊: CONTEMPORARY CLINICAL TRIALS
• 影响因子: 2.2
• 作者: Jayawardene, Wasantha;Pezalla, Annie;Henderson, Cris;Hecht, Michael
• 通讯作者: Hecht, Michael